A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance

OBJECTIVE: Real-life safety and efficacy of sorafenib in advanced renal cell carcinoma in a nationwide patient population were evaluated by post-marketing all-patient surveillance. METHODS: All patients with unresectable or metastatic renal cell carcinoma in Japan who started sorafenib therapy from...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaza, Hideyuki, Oya, Mototsugu, Iijima, Masafumi, Hyodo, Ichinosuke, Gemma, Akihiko, Itoh, Hiroshi, Adachi, Masatoshi, Okayama, Yutaka, Sunaya, Toshiyuki, Inuyama, Lyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598240/
https://www.ncbi.nlm.nih.gov/pubmed/26206897
http://dx.doi.org/10.1093/jjco/hyv099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598240/
https://www.ncbi.nlm.nih.gov/pubmed/26206897
http://dx.doi.org/10.1093/jjco/hyv099

Ejemplares similares